These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35487070)

  • 1. Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment.
    Wang R; Liang Q; Zhang X; Di Z; Wang X; Di L
    Colloids Surf B Biointerfaces; 2022 Jul; 215():112505. PubMed ID: 35487070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
    Si J; Li W; Li X; Cao L; Chen Z; Jiang Z
    Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/
    Han C; Wang S; Wang H; Zhang J
    Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821
    [No Abstract]   [Full Text] [Related]  

  • 4. Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.
    Liu HM; Zhang Y
    Kaohsiung J Med Sci; 2024 May; 40(5):435-444. PubMed ID: 38482902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide.
    Yang ZJ; Zhang LL; Bi QC; Gan LJ; Wei MJ; Hong T; Tan RJ; Lan XM; Liu LH; Han XJ; Jiang LP
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma.
    Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D
    J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Oxygenase-1 targeting exosomes for temozolomide resistant glioblastoma synergistic therapy.
    Rehman FU; Liu Y; Yang Q; Yang H; Liu R; Zhang D; Muhammad P; Liu Y; Hanif S; Ismail M; Zheng M; Shi B
    J Control Release; 2022 May; 345():696-708. PubMed ID: 35341901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.
    Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T
    Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873
    [No Abstract]   [Full Text] [Related]  

  • 9. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis.
    Deng Y; Zhu H; Xiao L; Liu C; Meng X
    Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes released from U87 glioma cells treated with curcumin and/or temozolomide produce apoptosis in naive U87 cells.
    Mousavi SM; Hosseindoost S; Mahdian SMA; Vousooghi N; Rajabi A; Jafari A; Ostadian A; Hamblin MR; Hadjighassem M; Mirzaei H
    Pathol Res Pract; 2023 May; 245():154427. PubMed ID: 37028110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in research and development of temozolomide brain-targeted preparations: a review.
    Yang J; Xu Y; Fu Z; Chen J; Fan W; Wu X
    J Drug Target; 2023 Feb; 31(2):119-133. PubMed ID: 36039767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype.
    Yu T; Wang X; Zhi T; Zhang J; Wang Y; Nie E; Zhou F; You Y; Liu N
    Cancer Lett; 2018 Oct; 433():210-220. PubMed ID: 30008386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IFN-beta on human glioma cell lines with temozolomide resistance.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E
    Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA-binding protein fragile-X mental retardation autosomal 1 (FXR1) modulates glioma cells sensitivity to temozolomide by regulating ferroptosis.
    Wei Y; Duan S; Gong F; Li Q
    Biochem Biophys Res Commun; 2022 May; 603():153-159. PubMed ID: 35294905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
    Yu Y; Wang A; Wang S; Sun Y; Chu L; Zhou L; Yang X; Liu X; Sha C; Sun K; Xu L
    Mol Pharm; 2022 Apr; 19(4):1219-1229. PubMed ID: 35262365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
    Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
    J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294.
    Hua L; Huang L; Zhang X; Feng H
    J Biosci; 2020; 45():. PubMed ID: 32975228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma.
    Hou X; Du H; Deng Y; Wang H; Liu J; Qiao J; Liu W; Shu X; Sun B; Liu Y
    J Transl Med; 2023 Mar; 21(1):198. PubMed ID: 36927689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.